Warmuth Markus
Insider CIK 1855643 · GLUE See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-07-16 | 2026-07-17 | 9,500 | $23.18 | $220.2K | 585,038 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-06-01 | 2026-06-02 | 468 | $19.73 | $9.2K | 594,538 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-06-01 | 2026-06-02 | 4,998 | $19.41 | $97.0K | 595,006 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-05-01 | 2026-05-05 | 5,467 | $18.92 | $103.4K | 600,004 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-04-14 | 2026-04-15 | 8,000 | $17.64 | $141.1K | 605,471 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-03-02 | 2026-03-04 | 5,466 | $17.92 | $98.0K | 613,471 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-01-07 | 2026-01-09 | 3,707 | $23.24 | $86.2K | 620,696 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-01-07 | 2026-01-09 | 1,450 | $23.88 | $34.6K | 619,246 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-01-07 | 2026-01-09 | 309 | $24.57 | $7.6K | 618,937 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-01-05 | 2026-01-05 | 10,135 | $15.17 | $153.7K | 624,403 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2026-01-02 | 2026-01-05 | 406,000 | — | $0 | 406,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award | 2026-01-02 | 2026-01-05 | 90,000 | — | $0 | 634,538 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2025-01-02 | 2025-01-06 | 575,000 | — | $0 | 575,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award | 2025-01-02 | 2025-01-06 | 128,000 | — | $0 | 544,538 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-01-02 | 2024-01-04 | 346,000 | — | $0 | 346,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2023-01-03 | 2023-01-04 | 472,000 | — | $0 | 472,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2022-03-01 | 2022-03-02 | 315,600 | — | $0 | 315,600 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2021-06-23 | 2021-06-25 | 141,623 | — | $0 | 141,623 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2021-04-12 | 2021-06-25 | 538,517 | — | $0 | 538,517 | SEC↗ |